**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 16925-25-0 |Antimonate(1-), hexafluoro-, sodium, (| 98.0 | 240-989-8 |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: XN
Risk Phrases: 20/22
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Harmful by inhalation and if swallowed.The toxicological properties
of this material have not been fully investigated.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation.
Ingestion:
Inorganic fluorides can be harmful. Acute exposure to fluorine
compounds can lead to digestive tract burns, and abdominal pain.
Exposure to fluoride compounds can result in systemic toxic effects
on the heart, liver, and kidneys. It may also deplete calcium levels
in the body leading to hypocalcemia and death.
Inhalation:
May cause respiratory tract irritation.
Chronic:
Chronic inhalation and ingestion may cause chronic fluoride
poisoning (fluorosis) characterized by weight loss, weakness,
anemia, brittle bones, and stiff joints. May cause liver and kidney
damage.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid
immediately.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15
minutes while removing contaminated clothing and shoes. Remove
contaminated clothing and shoes.
Ingestion:
If victim is conscious and alert, give 2-4 cupfuls of milk or water.
Never give anything by mouth to an unconscious person. Get medical
aid immediately. Do NOT induce vomiting. If conscious and alert,
rinse mouth and drink 2-4 cupfuls of milk or water.
Inhalation:
Get medical aid immediately. Remove from exposure and move to fresh
air immediately. If not breathing, give artificial respiration. If
breathing is difficult, give oxygen.
Notes to Physician:
Antidote:
None reported.
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion.
Extinguishing Media:
Use agent most appropriate to extinguish fire.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal
container. Clean up spills immediately, observing precautions in the
Protective Equipment section. Provide ventilation.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Remove contaminated clothing and
wash before reuse. Use with adequate ventilation. Minimize dust
generation and accumulation. Avoid contact with eyes, skin, and
clothing. Avoid ingestion and inhalation.
Storage:
Keep container closed when not in use. Store in a tightly closed
container. Store in a cool, dry, well-ventilated area away from
incompatible substances.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Use adequate ventilation to keep airborne concentrations low.
Exposure Limits
CAS# 16925-25-0:
United Kingdom, WEL - TWA: (listed as antimony): 0.5 mg/m3 TWA
United Kingdom, WEL - STEL: (listed as antimony): 1.5 mg/m3 STEL
United States OSHA: 0.5 mg/m3 TWA (listed under Antimony).
Belgium - TWA: (listed as antimony): 0.5 mg/m3 VLE
France - VME: (listed as antimony): 0.5 mg/m3 VME
Germany: (listed as antimony): 0.5 mg/m3 VME
Japan: (listed as antimony): 0.1 mg/m3 OEL
Malaysia: (listed as antimony): 0.5 mg/m3 TWA
Netherlands: (listed as antimony): 0.5 mg/m3 MAC
Russia: (listed as antimony): 0.5 mg/m3 TWA
Russia: (listed as antimony): 0.2 mg/m3 STEL
Spain: (listed as antimony): 0.5 mg/m3 VLA-ED
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective gloves to prevent skin
exposure.
Respirators:
Follow the OSHA respirator regulations found in 29
CFR 1910.134 or European Standard EN 149. Use a
NIOSH/MSHA or European Standard EN 149 approved
respirator if exposure limits are exceeded or if
irritation or other symptoms are experienced.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Solid
Color: white
Odor: Odorless.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: Not available.
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water: very soluble in water
Specific Gravity/Density:
Molecular Formula: F6NaSb
Molecular Weight: 258.72
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials, dust generation, strong oxidants.
Incompatibilities with Other Materials:
Strong oxidizing agents - strong acids.
Hazardous Decomposition Products:
Irritating and toxic fumes and gases, hydrogen fluoride gas.
Hazardous Polymerization: Has not been reported
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 16925-25-0 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
Antimonate(1-), hexafluoro-, sodium, (oc-6-11)- -
Not listed by ACGIH, IARC, or NTP.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Shipping Name: TOXIC SOLID, ORGANIC, N.O.S.*
Hazard Class: 6.1
UN Number: 2811
Packing Group: III
IMO
Shipping Name: TOXIC SOLID, ORGANIC, N.O.S.
Hazard Class: 6.1
UN Number: 2811
Packing Group: III
RID/ADR
Shipping Name: TOXIC SOLID, ORGANIC, N.O.S.
Hazard Class: 6.1
UN Number: 2811
Packing group: III
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 20/22 Harmful by inhalation and if swallowed.
Safety Phrases:
S 22 Do not breathe dust.
WGK (Water Danger/Protection)
CAS# 16925-25-0: No information available.
Canada
CAS# 16925-25-0 is listed on Canada's NDSL List.
CAS# 16925-25-0 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 16925-25-0 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 3/09/1999 Revision #2 Date: 3/18/2003
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
Monomethyl monopotassiummalonate, 98%
| 38330-80-2 |
|
4-Bromomandelic Acid, 96% (HPLC)
| 6940-50-7 |
|
Stigmasterol, 95%
| 83-48-7 |
|
2-Chloro-6-Nitrotoluene, 99%
| 83-42-1 |
|
[Tris(trimethylsilyl)]arsenide, 98%
| 17729-30-5 |
|
1-Ethylquinaldinium Iodide, 97% (titr.)
| 606-55-3 |
|
L-Aspartyl-L-Phenylalanine Methyl Ester, 98%
| 22839-47-0 |
|
Primaquine diphosphate, 99+%
| 63-45-6 |
|
Ethyl 5-Hydroxy-2-Methylindole-3- Carboxylate
| 7598-91-6 |
|
(R)-(-)-1-Amino-2-Propanol, 98+%
| 2799-16-8 |
|
N-Methylthiourea, 97%
| 598-52-7 |
|
2,3,4,5,6-Pentafluoroanisole, 97+%
| 389-40-2 |
|
Cyclohexene Oxide, 98%
| 286-20-4 |
|
5-beta-Pregnane-3-alpha,20-alpha-diol, 99%
| 80-92-2 |
|
Cyclooctene Oxide, 99%
| 286-62-4 |
|
2-(4-Methoxyphenyl)-4,6-Diphenylpyrylium Tetrafluoroborate
| 2907-13-3 |
|
Sodium Hexafluoroantimonate, 98% (Titr.)
| 16925-25-0 |
|
Ethylene/Acrylic Acid Copolymer
| 9010-77-9 |
|
4-Fluoro-2-Nitrotoluene, 98%
| 446-10-6 |
|
N-Carbethoxy-4-Piperidone, 97+%
| 29976-53-2 |
|
3-Methylhippuric acid,98+%
| 27115-49-7 |
|
Amberlite cg-400 ion-exchange resin
| 37247-87-3 |
|
3-Nitrotoluene, 99%
| 99-08-1 |
|
1,3-Diphenylguanidine, 99% (uv-vis)
| 102-06-7 |
|
2-Bromo-4-Methylaniline, 98%
| 583-68-6 |
|
2,2'-Bithiophene
| 492-97-7 |
|
5,6-Dimethylbenzimidazole, 99+%
| 582-60-5 |
|
4-Butoxyaniline, 99% (titr.)
| 4344-55-2 |
|
Alpha-Cyano-O-Tolunitrile, Tech.
| 3759-28-2 |
|
DL-Laudanosoline Hydrobromide Trihydrate, 98%
| 485-33-6 |
|
4-Chloro-6-Nitro-Meta-Cresol, 99%
| 7147-89-9 |
|
2-Butanone oxime, 99%
| 96-29-7 |
|
Hexachloropropene, 96%
| 1888-71-7 |
|
Isopropyl Chloroacetate, 99%
| 105-48-6 |
|
3-Methylpentane, 99+%
| 96-14-0 |
|
1,4-Cyclohexanedicarboxylic Acid, 96% (Titr.)
| 1076-97-7 |
|
Azoxybenzene, 97%
| 495-48-7 |
|
l-(+)-Lactic acid, lithium salt
| 27848-80-2 |
|
4-Hexylresorcinol, 99%
| 136-77-6 |
|
Tantalum (V) Chloride, 99.9%
| 7721-01-9 |
|
2,4,5-Trimethylthiazole, 99%
| 13623-11-5 |
|
Cycloheptane, 99%
| 291-64-5 |
|
Phenylglyoxal monohydrate, 97%
| 1074-12-0 |
|
Ethyl Carbazate, 97%
| 4114-31-2 |
|
bis(Methylthio)methane, 99+%
| 1618-26-4 |
|
1-Bromo-4-Tert-Butylbenzene, 97+%
| 3972-65-4 |
|
(S)-(+)-2-Amino-2-methylbutanoic acid monohydrate, 99+% (>99% e.e.)
| 0-00-0 |
|
2-Furonitrile, 99%
| 617-90-3 |
|
l-Adrenaline, 97% (titr.)
| 51-43-4 |
|
4-(3-Methyl-5-oxo-2-pyrazolin-1-yl)benzoic acid, 98+%
| 60875-16-3 |
|
|